Cargando…
Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition
Cell competition has recently emerged as an important tumor suppressor mechanism in the thymus that inhibits autonomous thymic maintenance. Here, we show that the oncogenic transcription factor Lmo2 causes autonomous thymic maintenance in transgenic mice by inhibiting early T cell differentiation. T...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037042/ https://www.ncbi.nlm.nih.gov/pubmed/36920307 http://dx.doi.org/10.1084/jem.20212383 |
_version_ | 1784911797735653376 |
---|---|
author | Abdulla, Hesham D. Alserihi, Raed Flensburg, Christoffer Abeysekera, Waruni Luo, Meng-Xiao Gray, Daniel H.D. Liu, Xiaodong Smyth, Gordon K. Alexander, Warren S. Majewski, Ian J. McCormack, Matthew P. |
author_facet | Abdulla, Hesham D. Alserihi, Raed Flensburg, Christoffer Abeysekera, Waruni Luo, Meng-Xiao Gray, Daniel H.D. Liu, Xiaodong Smyth, Gordon K. Alexander, Warren S. Majewski, Ian J. McCormack, Matthew P. |
author_sort | Abdulla, Hesham D. |
collection | PubMed |
description | Cell competition has recently emerged as an important tumor suppressor mechanism in the thymus that inhibits autonomous thymic maintenance. Here, we show that the oncogenic transcription factor Lmo2 causes autonomous thymic maintenance in transgenic mice by inhibiting early T cell differentiation. This autonomous thymic maintenance results in the development of self-renewing preleukemic stem cells (pre-LSCs) and subsequent leukemogenesis, both of which are profoundly inhibited by restoration of thymic competition or expression of the antiapoptotic factor BCL2. Genomic analyses revealed the presence of Notch1 mutations in pre-LSCs before subsequent loss of tumor suppressors promotes the transition to overt leukemogenesis. These studies demonstrate a critical role for impaired cell competition in the development of pre-LSCs in a transgenic mouse model of T cell acute lymphoblastic leukemia (T-ALL), implying that this process plays a role in the ontogeny of human T-ALL. |
format | Online Article Text |
id | pubmed-10037042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-100370422023-09-15 Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition Abdulla, Hesham D. Alserihi, Raed Flensburg, Christoffer Abeysekera, Waruni Luo, Meng-Xiao Gray, Daniel H.D. Liu, Xiaodong Smyth, Gordon K. Alexander, Warren S. Majewski, Ian J. McCormack, Matthew P. J Exp Med Article Cell competition has recently emerged as an important tumor suppressor mechanism in the thymus that inhibits autonomous thymic maintenance. Here, we show that the oncogenic transcription factor Lmo2 causes autonomous thymic maintenance in transgenic mice by inhibiting early T cell differentiation. This autonomous thymic maintenance results in the development of self-renewing preleukemic stem cells (pre-LSCs) and subsequent leukemogenesis, both of which are profoundly inhibited by restoration of thymic competition or expression of the antiapoptotic factor BCL2. Genomic analyses revealed the presence of Notch1 mutations in pre-LSCs before subsequent loss of tumor suppressors promotes the transition to overt leukemogenesis. These studies demonstrate a critical role for impaired cell competition in the development of pre-LSCs in a transgenic mouse model of T cell acute lymphoblastic leukemia (T-ALL), implying that this process plays a role in the ontogeny of human T-ALL. Rockefeller University Press 2023-03-15 /pmc/articles/PMC10037042/ /pubmed/36920307 http://dx.doi.org/10.1084/jem.20212383 Text en © 2023 Abdulla et al. https://creativecommons.org/licenses/by-nc-sa/4.0/http://www.rupress.org/terms/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Abdulla, Hesham D. Alserihi, Raed Flensburg, Christoffer Abeysekera, Waruni Luo, Meng-Xiao Gray, Daniel H.D. Liu, Xiaodong Smyth, Gordon K. Alexander, Warren S. Majewski, Ian J. McCormack, Matthew P. Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition |
title | Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition |
title_full | Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition |
title_fullStr | Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition |
title_full_unstemmed | Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition |
title_short | Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition |
title_sort | overexpression of lmo2 initiates t-lymphoblastic leukemia via impaired thymocyte competition |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037042/ https://www.ncbi.nlm.nih.gov/pubmed/36920307 http://dx.doi.org/10.1084/jem.20212383 |
work_keys_str_mv | AT abdullaheshamd overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition AT alserihiraed overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition AT flensburgchristoffer overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition AT abeysekerawaruni overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition AT luomengxiao overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition AT graydanielhd overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition AT liuxiaodong overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition AT smythgordonk overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition AT alexanderwarrens overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition AT majewskiianj overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition AT mccormackmatthewp overexpressionoflmo2initiatestlymphoblasticleukemiaviaimpairedthymocytecompetition |